Onan Elvan, Bulut Fatma Derya, Kor Deniz, Dagkiran Muhammed, Eker Caglar, Surmelioglu Ozgur, Önenli Mungan Neslihan
Department of Otorhinolaryngology, Faculty of Medicine, Çukurova University, Adana, Turkey.
Faculty of Medicine, Department of Pediatric Metabolism and Nutrition, Department of Pediatrics, Çukurova University, Adana, Turkey.
J Inherit Metab Dis. 2025 Jul;48(4):e70046. doi: 10.1002/jimd.70046.
Gaucher disease (GD), the most prevalent lysosomal storage disorder, is characterized by varying levels of systemic and neurological involvement. This study aims to investigate audiovestibular system involvement in patients with Gaucher disease type I (GD1) and type III (GD3) using audiometric and vestibular evaluations. We conducted a retrospective analysis of 42 patients diagnosed with GD who presented to the Department of Otorhinolaryngology at Çukurova University Faculty of Medicine between January 2001 and September 2023. The evaluations included pure tone audiometry (PTA), speech discrimination scores (SDS), acoustic impedance tests, and Video Head Impulse Test (vHIT) assessments. Of the 42 patients, 18 were diagnosed with GD1, and 24 with GD3. Audiovestibular anomalies were identified in 11 patients (26.2%). Sensorineural hearing loss (SNHL) was detected in 9 patients, including 4 GD1 and 5 GD3 patients, with bilateral involvement in 5 cases. The severity of hearing loss ranged from mild to moderately severe. Vestibular impairment, demonstrated by reduced vestibulo-ocular reflex (VOR) gain and catch-up saccades (CUS), was observed in 5 patients, predominantly among GD3 cases. Notably, concurrent audiovestibular dysfunction was observed in three patients, one with GD1 and two with GD3. This study is the first to describe the vestibular involvement in GD1. Audiovestibular abnormalities can manifest in both GD1 and GD3 patients, with distinct patterns of involvement. Regular auditory and vestibular assessments are essential to identify sensory deficits early, guide rehabilitation strategies, and enhance the quality of life for GD patients.
戈谢病(GD)是最常见的溶酶体贮积症,其特征是全身和神经受累程度各异。本研究旨在通过听力和前庭评估,调查Ⅰ型戈谢病(GD1)和Ⅲ型戈谢病(GD3)患者的听前庭系统受累情况。我们对2001年1月至2023年9月期间在库库罗瓦大学医学院耳鼻喉科就诊的42例确诊为GD的患者进行了回顾性分析。评估包括纯音听力测定(PTA)、言语辨别分数(SDS)、声阻抗测试和视频头脉冲测试(vHIT)评估。42例患者中,18例诊断为GD1,24例诊断为GD3。11例患者(26.2%)发现听前庭异常。9例患者检测到感音神经性听力损失(SNHL),其中4例为GD1患者,5例为GD3患者,5例为双侧受累。听力损失的严重程度从轻度到中度重度不等。在前庭功能减退方面,5例患者观察到前庭眼反射(VOR)增益降低和矫正性扫视(CUS),主要发生在GD3病例中。值得注意的是,3例患者同时存在听前庭功能障碍,1例为GD1患者,2例为GD3患者。本研究首次描述了GD1患者的前庭受累情况。GD1和GD3患者均可出现听前庭异常,且受累模式不同。定期进行听觉和前庭评估对于早期识别感觉缺陷、指导康复策略以及提高GD患者的生活质量至关重要。